2m 2m 2m 2m 2m 2m 2m
CITIUS PHARMACTC (CTXR)
NASDAQ
$0.38+$0.01 (+2.75%)
Price as of Oct 22, 2026 7:55 PM EDT- $10.9MMarket Cap
- -74.81%1-Year Change
- BiotechnologyIndustry
CITIUS PHARMACTC (CTXR)
$0.38+$0.01 (+2.75%)
CTXR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.37 | ||
Change | -$0.02 (-6.25%) | ||
Open | $0.39 | ||
High | $0.39 | ||
Low | $0.37 | ||
Previous Close | $0.40 | ||
Volume | 341,367 | ||
30-Day Average Volume | 212,589 | ||
1-Week Change | -19.39% | ||
1-Month Change | -38.01% | ||
1-Year Change | -78.44% | ||
3-Year Change | -97.87% | ||
5-Year Change | -99.24% | ||
Fundamentals | |||
Shares Outstanding | 27.5M | ||
Total Assets | $142.3M | ||
Market Cap | $10.9M | ||
Enterprise Value | $300.3M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$11.9M | ||
Free Cash Flow | -$8.7M | ||
EBIT | -$11.8M | ||
EBITDA | -$10.1M | ||
Net Working Capital | -$8.3M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | 201 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 11/26/2024 | ||